Home Infusion Therapy Devices Market to Witness Stunning Growth by 2031

According to a recent study by Future Market Insights (FMI), sales of home infusion therapy devices are expected to top US$ 2.0 Bn in 2021, growing at a CAGR of over 6.5% during the forecast period (2021-2031).

 

Home infusion therapy devices are used for the intravenous administration of medicines. It is commonly prescribed for patients with serious infections and specialized diseases when orally administered medicines are not or comparatively less effective.

 

Application of home infusion therapy devices is increasing with the rising number of surgeries conducted across the globe. Post-surgery pain management at home can be done with the help of home infusion therapy devices.

 

Besides this, rising healthcare expenditure and growing awareness regarding the risk and infection amidst the outbreak of COVID-19 is driving the demand of home infusion therapy devices.

 

 

 

By product type, infusion system accessories will hold around 45% of value share globally. Based on the application, antibiotic administration is leading with over 34% of the market share. Home care settings sales will dominate the home infusion therapy devices, with a market share of 65% during the forecast period. By region, the U.S. will dominate the global home infusion therapy devices market with a value share of around 37% during the forecast period. Followed by North America, Europe will be the second-largest leading region, with a value share of 93.2% during the forecast period. India is the dominant country in term of revenue for South Asia Home infusion therapy devices market, accounting for nearly 48% of market share in 2021. China holds leading position in East Asia and is expected to account for nearly 52% of market share.

Key players are focusing on new product launches and approvals. Other growth strategies adopted by leading players include, agreements, and collaborations among key manufacturers. By focusing on these strategies, key players are expanding their geographic presence and strengthening their existing product portfolio.

 

The key market players profiled by FMI include Becton, Diciknson & Company, B.Braun Melsungen AG, Baxter International, Fresenius Kabi, Terumo Corporation, ICU Medical, Nipro Corporation, Smiths Medical, Micrel Medical Devices SA, Moog Inc., JMS Co. Ltd., Intera Oncology, and Others Top-up.

 

 

 

• Comprehensive analysis on evolving purchase pattern across different geographies

• Detailed insights of market segments and sub-segments for historical as well as forecast period

• A competitive analysis of prominent players and emerging players in the keyword market

• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

 

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

 

 

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

 

 

Mr. Debashish Roy

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Website: https://www.futuremarketinsights.com